Nasal Packing Devices Market Share, Growth, Trends | Report 2022-2030
The global nasal packing devices market was surpassed at USD 173.1 million in 2021 and is expected to hit around USD 271.2 million by 2030, growing at a CAGR of 5.12% from 2022 to 2030.
This is attributed to the increasing prevalence of epistaxis and the ever-growing geriatric population. The demand for nasal packing devices is constantly on the rise, as epistaxis, also known as a nosebleed, is a commonly occurring condition. However, it is not severe in every case, and therefore people used to pay minute attention to it. But since the population has become increasingly health-conscious, many people opt to get it treated before the condition worsens.
The use of nasal packing devices increased significantly during the COVID-19 pandemic. The spread of the virus was a constant threat to healthcare professionals and patients during the pandemic. Hence, patients that suffered from epistaxis could be discharged from hospitals by applying nasal packing which, with little training, could be replaced and removed at home itself. This relieved the pressure on the hospital and minimized Epistaxis patient visits. Epistaxis, if left untreated, is a constantly occurring condition and can cause high discomfort and pain to the patient. In severe cases, it may also lead to fatality. Therefore, medical professionals first try to eliminate epistaxis through electric cauterization.
In case of failure of cauterization, nasal packing is used on the site of bleeding in the nasal cavity to create pressure and control the bleeding. In epistaxis conditions, a nasal packing can prove beneficial by achieving hemostasis, preventing desiccation, protecting the site from trauma, applying constant pressure to the mucosal walls, and protecting the nasal cavity. Nasal packing is highly used to control nasal bleeding as its advantages far outweigh the disadvantages. Post-packing care is taken by doctors to ensure patient safety. Manufacturers are also constantly investing in research and development of new products that can overcome these complications. In December 2020, Medtronic launched Novapak Nasal Sinus Packing and Stent, a single-use, dissolvable packing, intended post sinus surgery. It proved highly effective in bleeding control, prevention of adhesions, and providing a moist healing atmosphere for quick patient recovery.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 173.1 million |
| Revenue Forecast by 2030 | USD 271.2 million |
| Growth rate from 2022 to 2030 | CAGR of 5.12% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Product, type, region |
| Companies Covered | Summit Health; Smith & Nephew; Stryker Corporation; Medtronic plc.; Network medical products ltd.; Olympus; Lohmann & Rauscher; Meril Life Sciences Pvt Ltd.; FABCO; Aegis Lifesciences |
Product Insights
The spray segment dominated the market in terms of the revenue share of around 30.0% in 2021. Spray nasal packing is an upcoming product and is directly applied into the nasal cavity or onto cotton balls that are placed in the cavity. The types of nasal sprays available are saline and decongestant.
The gel packing segment is likely to witness the fastest growth rate over the forecast period. The recent developments and efficacy of gel production, owing to the high patient comfort and its hemostatic properties are expected to contribute to the segment growth. Gel and dressings are the most common and effective products for the treatment of nosebleeds. There are various dressing brands available in the market. MeroGel by Medtronic is one of the popular nasal dressings in the market. Injectable nasal packing is particularly indicated to avoid lateralization of the central turbinate and also nasal adhesions in the post-surgery period.
Type Insights
In 2021, the non-absorbable segment held a majority of the market share of around 55% in terms of revenue. The non-absorbable nasal packing devices is an already well-established and preferred by physicians and are also comparatively cheaper than the bioresorbable nasal packing devices.
The bioresorbable segment is likely to witness the fastest growth rate over the forecast period owing to the rapid technological advancements and the increasing introduction of newer brands into the market. Bioresorbable nasal packing devices are much more convenient to the patients as there is much less pain and has more advantages than their counterpart segment.
Regional Insights
In 2021, North America dominated the market in terms of revenue share owing to the growing adoption of nasal packing devices to treat the ever-increasing numbers of epistaxis patients and the increasing number of market players in the region. Moreover, increased COVID-19 cases in the region further boosted the demand for nasal packing devices.
In the Asia Pacific, the market is projected to witness a promising growth rate in the forecast period from 2022 to 2030. This growth can be attributed to the increase in the number of nasal packing device manufacturers, high unmet needs, booming economy, and overall improving healthcare infrastructure, especially in developing countries such as China and India. In addition, the increased awareness about nasal packing devices and their applications attribute to the growth of the market.
Key Players
Market Segmentation
By Product Outlook
By Type Outlook
By Regional Outlook
Chapter 1.Introduction
1.1.Research Objective
1.2.Scope of the Study
1.3.Definition
Chapter 2.Research Methodology
2.1.Research Approach
2.2.Data Sources
2.3.Assumptions & Limitations
Chapter 3.Executive Summary
3.1.Market Snapshot
Chapter 4.Market Variables and Scope
4.1.Introduction
4.2.Market Classification and Scope
4.3.Industry Value Chain Analysis
4.3.1.Raw Material Procurement Analysis
4.3.2.Sales and Distribution Channel Analysis
4.3.3.Downstream Buyer Analysis
Chapter 5.COVID 19 Impact on Nasal Packing Devices Market
5.1.COVID-19 Landscape: Nasal Packing Devices Industry Impact
5.2.COVID 19 - Impact Assessment for the Industry
5.3.COVID 19 Impact: Global Major Government Policy
5.4.Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6.Market Dynamics Analysis and Trends
6.1.Market Dynamics
6.1.1.Market Drivers
6.1.2.Market Restraints
6.1.3.Market Opportunities
6.2.Porter’s Five Forces Analysis
6.2.1.Bargaining power of suppliers
6.2.2.Bargaining power of buyers
6.2.3.Threat of substitute
6.2.4.Threat of new entrants
6.2.5.Degree of competition
Chapter 7.Competitive Landscape
7.1.1.Company Market Share/Positioning Analysis
7.1.2.Key Strategies Adopted by Players
7.1.3.Vendor Landscape
7.1.3.1.List of Suppliers
7.1.3.2.List of Buyers
Chapter 8.Global Nasal Packing Devices Market, By Product
8.1.Nasal Packing Devices Market, by Product Type, 2022-2030
8.1.1.Injectable
8.1.1.1.Market Revenue and Forecast (2017-2030)
8.1.2.Gel
8.1.2.1.Market Revenue and Forecast (2017-2030)
8.1.3.Spray
8.1.3.1.Market Revenue and Forecast (2017-2030)
8.1.4.Dressings
8.1.4.1.Market Revenue and Forecast (2017-2030)
Chapter 9.Global Nasal Packing Devices Market, By Type
9.1.Nasal Packing Devices Market, by Type, 2022-2030
9.1.1.Bio-resorbable
9.1.1.1.Market Revenue and Forecast (2017-2030)
9.1.2.Non-absorbable
9.1.2.1.Market Revenue and Forecast (2017-2030)
Chapter 10.Global Nasal Packing Devices Market, Regional Estimates and Trend Forecast
10.1.North America
10.1.1.Market Revenue and Forecast, by Product (2017-2030)
10.1.2.Market Revenue and Forecast, by Type (2017-2030)
10.1.3.U.S.
10.1.3.1.Market Revenue and Forecast, by Product (2017-2030)
10.1.3.2.Market Revenue and Forecast, by Type (2017-2030)
10.1.4.Rest of North America
10.1.4.1.Market Revenue and Forecast, by Product (2017-2030)
10.1.4.2.Market Revenue and Forecast, by Type (2017-2030)
10.2.Europe
10.2.1.Market Revenue and Forecast, by Product (2017-2030)
10.2.2.Market Revenue and Forecast, by Type (2017-2030)
10.2.3.UK
10.2.3.1.Market Revenue and Forecast, by Product (2017-2030)
10.2.3.2.Market Revenue and Forecast, by Type (2017-2030)
10.2.4.Germany
10.2.4.1.Market Revenue and Forecast, by Product (2017-2030)
10.2.4.2.Market Revenue and Forecast, by Type (2017-2030)
10.2.5.France
10.2.5.1.Market Revenue and Forecast, by Product (2017-2030)
10.2.5.2.Market Revenue and Forecast, by Type (2017-2030)
10.2.6.Rest of Europe
10.2.6.1.Market Revenue and Forecast, by Product (2017-2030)
10.2.6.2.Market Revenue and Forecast, by Type (2017-2030)
10.3.APAC
10.3.1.Market Revenue and Forecast, by Product (2017-2030)
10.3.2.Market Revenue and Forecast, by Type (2017-2030)
10.3.3.India
10.3.3.1.Market Revenue and Forecast, by Product (2017-2030)
10.3.3.2.Market Revenue and Forecast, by Type (2017-2030)
10.3.4.China
10.3.4.1.Market Revenue and Forecast, by Product (2017-2030)
10.3.4.2.Market Revenue and Forecast, by Type (2017-2030)
10.3.5.Japan
10.3.5.1.Market Revenue and Forecast, by Product (2017-2030)
10.3.5.2.Market Revenue and Forecast, by Type (2017-2030)
10.3.6.Rest of APAC
10.3.6.1.Market Revenue and Forecast, by Product (2017-2030)
10.3.6.2.Market Revenue and Forecast, by Type (2017-2030)
10.4.MEA
10.4.1.Market Revenue and Forecast, by Product (2017-2030)
10.4.2.Market Revenue and Forecast, by Type (2017-2030)
10.4.3.GCC
10.4.3.1.Market Revenue and Forecast, by Product (2017-2030)
10.4.3.2.Market Revenue and Forecast, by Type (2017-2030)
10.4.4.North Africa
10.4.4.1.Market Revenue and Forecast, by Product (2017-2030)
10.4.4.2.Market Revenue and Forecast, by Type (2017-2030)
10.4.5.South Africa
10.4.5.1.Market Revenue and Forecast, by Product (2017-2030)
10.4.5.2.Market Revenue and Forecast, by Type (2017-2030)
10.4.6.Rest of MEA
10.4.6.1.Market Revenue and Forecast, by Product (2017-2030)
10.4.6.2.Market Revenue and Forecast, by Type (2017-2030)
10.5.Latin America
10.5.1.Market Revenue and Forecast, by Product (2017-2030)
10.5.2.Market Revenue and Forecast, by Type (2017-2030)
10.5.3.Brazil
10.5.3.1.Market Revenue and Forecast, by Product (2017-2030)
10.5.3.2.Market Revenue and Forecast, by Type (2017-2030)
10.5.4.Rest of LATAM
10.5.4.1.Market Revenue and Forecast, by Product (2017-2030)
10.5.4.2.Market Revenue and Forecast, by Type (2017-2030)
Chapter 11.Company Profiles
11.1.Summit Health
11.1.1.Company Overview
11.1.2.Product Offerings
11.1.3.Financial Performance
11.1.4.Recent Initiatives
11.2.Smith & Nephew
11.2.1.Company Overview
11.2.2.Product Offerings
11.2.3.Financial Performance
11.2.4.Recent Initiatives
11.3.Stryker Corporation
11.3.1.Company Overview
11.3.2.Product Offerings
11.3.3.Financial Performance
11.3.4.Recent Initiatives
11.4.Medtronic plc.
11.4.1.Company Overview
11.4.2.Product Offerings
11.4.3.Financial Performance
11.4.4.Recent Initiatives
11.5.Network medical products ltd.
11.5.1.Company Overview
11.5.2.Product Offerings
11.5.3.Financial Performance
11.5.4.Recent Initiatives
11.6.Olympus
11.6.1.Company Overview
11.6.2.Product Offerings
11.6.3.Financial Performance
11.6.4.Recent Initiatives
11.7.Lohmann & Rauscher
11.7.1.Company Overview
11.7.2.Product Offerings
11.7.3.Financial Performance
11.7.4.Recent Initiatives
11.8.Meril Life Sciences Pvt Ltd.
11.8.1.Company Overview
11.8.2.Product Offerings
11.8.3.Financial Performance
11.8.4.Recent Initiatives
11.9.FABCO
11.9.1.Company Overview
11.9.2.Product Offerings
11.9.3.Financial Performance
11.9.4.Recent Initiatives
11.10.Aegis Lifesciences
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12.Research Methodology
12.1.Primary Research
12.2.Secondary Research
12.3.Assumptions
Chapter 13.Appendix
13.1.About Us
13.2.Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers